Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 · Journal of Clinical Oncology · 4,815 citations
https://doi.org/10.1200/jco.2008.18.1370
M
Maggie C.U. Cheang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
467
Papers
33.9K
Citations
64
h-index
116
i10-index
Maggie C.U. Cheang is an academic researcher from Institute of Cancer Research. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 64, co-authored 397 publications.
ORCID: 0000-0001-5718-2501Papers by this author
worksImmunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
2004 · Clinical Cancer Research · 2,642 citations
https://doi.org/10.1158/1078-0432.ccr-04-0220
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 · JNCI Journal of the National Cancer Institute · 2,199 citations
https://doi.org/10.1093/jnci/djp082
Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
2013 · The Oncologist · 537 citations
https://doi.org/10.1634/theoncologist.2012-0397
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
2007 · BMC Cancer · 367 citations
https://doi.org/10.1186/1471-2407-7-134
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
2011 · Breast Cancer Research and Treatment · 356 citations
https://doi.org/10.1007/s10549-011-1895-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat